4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-16-093158
Director sold 300,000 shares at $2.35 ($705,000)
From the SEC's structured data for this filing
Trades in this filing
KINGSLEY ALFRED D · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-01-20 | Sale : show line 1 in the form | −300,000 | $2.35 | $705,000 | 5,638,055 | D |
| Open-market sales · 300,000 sh · avg $2.35 · $705,000 | ||||||
Loading xslF345X03/doc4.xml…